- Home
- DNLI vs HASI Comparison
DNLI vs HASI Comparison
Compare DNLI & HASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- HASI
- Stock Information
- Founded
- DNLI 2013
- HASI 1981
- Country
- DNLI United States
- HASI United States
- Employees
- DNLI N/A
- HASI N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- HASI Real Estate Investment Trusts
- Sector
- DNLI Health Care
- HASI Real Estate
- Exchange
- DNLI Nasdaq
- HASI Nasdaq
- Market Cap
- DNLI 4.5B
- HASI 3.9B
- IPO Year
- DNLI 2017
- HASI 2013
- Fundamental
- Price
- DNLI $25.05
- HASI $27.20
- Analyst Decision
- DNLI Strong Buy
- HASI Buy
- Analyst Count
- DNLI 11
- HASI 12
- Target Price
- DNLI $38.90
- HASI $39.75
- AVG Volume (30 Days)
- DNLI 788.0K
- HASI 1.5M
- Earning Date
- DNLI 11-06-2024
- HASI 11-07-2024
- Dividend Yield
- DNLI N/A
- HASI 6.10%
- EPS Growth
- DNLI N/A
- HASI 358.98
- EPS
- DNLI N/A
- HASI 1.82
- Revenue
- DNLI N/A
- HASI $139,077,000.00
- Revenue This Year
- DNLI N/A
- HASI N/A
- Revenue Next Year
- DNLI $283.75
- HASI $5.73
- P/E Ratio
- DNLI N/A
- HASI $14.99
- Revenue Growth
- DNLI 204.74
- HASI 14.37
- 52 Week Low
- DNLI $14.56
- HASI $21.77
- 52 Week High
- DNLI $33.33
- HASI $36.56
- Technical
- Relative Strength Index (RSI)
- DNLI 37.93
- HASI 27.18
- Support Level
- DNLI $26.17
- HASI $26.93
- Resistance Level
- DNLI $33.33
- HASI $36.56
- Average True Range (ATR)
- DNLI 1.64
- HASI 1.49
- MACD
- DNLI -0.13
- HASI -0.79
- Stochastic Oscillator
- DNLI 0.66
- HASI 3.35
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About HASI Hannon Armstrong Sustainable Infrastructure Capital Inc.
Hannon Armstrong Sustainable Infrastructure Capital Inc provides debt and equity financing to the energy markets in the United States. The company focuses on investments in two types of projects: energy-efficiency projects and renewable-energy projects. Energy-efficiency projects reduce the energy use and energy cost of building or facility through the improvement or installation of building components including heat, ventilation, and air conditioning systems; lights; energy controls; roofs; windows; building shells; and heat and power systems. Renewable-energy projects deploy cleaner energy sources such as solar and wind to generate power production. The company also provides financing solutions for other projects to improve energy efficiency and the environment.